pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, alzheimer's disease, anxiety disorders, atopic dermatiti Read More

Classification Information

Class [005]
Pharmaceutical preparations namely pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders namely osteoporosis, osteoarthritis, fracture healing, bone frailty due to extended ventilator use, hip replacement surgery and knee replacement surgery, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, arthritis, bursitis, tendonitis, osteonecrosis and Paget's disease, cancer, cardiovascular diseases, central nervous system diseases and disorders namely, anxiety disorders, depression, bipolar depression, bipolar disorder, treatment resistant depression, schizophrenia and cognitive impairment associated with schizophrenia, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders namely psoriasis, skin cancer and eczema, diabetes, dyslipidemia, endocrine diseases and disorders, namely Type 2 Diabetes Mellitus and Type 1 Diabetes Mellitus, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders namely inflammatory bowel diseases, inflammatory connective tissue diseases and rheumatoid arthritis, kidney diseases and disorders, liver diseases and disorders, lupus, mental diseases and disorders, namely mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, and cerebral palsy, metabolic diseases and disorders namely metabolic syndrome, migraines, multiple sclerosis, muscle diseases and disorders namely myopathies, chronic fatigue syndrome, fibromyalgia and muscular dystrophy, neurodegenerative diseases and disorders namely Huntington's disease, Alzheimer's disease, and dementia, neurological disorders namely Alzheimer's disease, mild cognitive impairment, Parkinson's disease and multiple sclerosis, obesity, pain relief, Parkinson's disease, psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic reagents for medical diagnostic use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain.

Classification kind code

Mark Details

Serial Number

1870224

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 24^th May 2019	Allowed
Submitted for opposition 51 on 24^th May 2019	Allowance Notice Sent
Submitted for opposition 42 on 06^th Feb 2019	Advertised
Submitted for opposition 26 on 17^th Jan 2019	Approved
Submitted for opposition 27 on 26^th Nov 2018	Approval Notice Sent
Submitted for opposition 22 on 16^th Jul 2018	Search Recorded
Submitted for opposition 20 on 16^th Jul 2018	Examiner's First Report
Submitted for opposition 31 on 01^st Dec 2017	Formalized
Submitted for opposition 1 on 29^th Nov 2017	Created
Submitted for opposition 30 on 28^th Nov 2017	Filed